Mersana Therapeutics Inc (NASDAQ:MRSN) shares, rose in value on Thursday, December 12, with the stock price down by -14.18% to the previous day’s close as strong demand from buyers drove the stock to $2.30.
Actively observing the price movement in the last trading, the stock closed the session at $2.68, falling within a range of $2.245 and $2.71. Referring to stock’s 52-week performance, its high was $6.28, and the low was $1.22. On the whole, MRSN has fluctuated by 4.55% over the past month.
With the market capitalization of Mersana Therapeutics Inc currently standing at about $284.13 million, investors are eagerly awaiting this quarter’s results, scheduled for in January.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 31.77M, with a low estimate of 1M and a high estimate of 12.6M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 7.64M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MRSN’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a Hold.
The stock’s technical analysis shows that the price of MRSN currently trading nearly 0.57% and 6.13% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 50.32, while the 7-day volatility ratio is showing 15.17% which for the 30-day chart, stands at 12.21%. Furthermore, Mersana Therapeutics Inc (MRSN)’s beta value is 1.34, and its average true range (ATR) is 0.26.
A comparison of Mersana Therapeutics Inc (MRSN) with its peers suggests the former has fared considerably weaker in the market. MRSN showed an intraday change of -14.18% in last session, and over the past year, it grew by 13.86%%.
Data on historical trading for Mersana Therapeutics Inc (NASDAQ:MRSN) indicates that the trading volumes over the past 10 days have averaged 0.88 and over the past 3 months, they’ve averaged 1.07 million. According to company’s latest data on outstanding shares, there are 122.87 million shares outstanding.
Nearly 29.93% of Mersana Therapeutics Inc’s shares belong to company insiders and institutional investors own 66.09% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 8.75 million shares as on 2024-11-29, resulting in a short ratio of 6.45. According to the data, the short interest in Mersana Therapeutics Inc (MRSN) stood at 930.00 of shares outstanding as of 2024-11-29; the number of short shares registered in 2024-10-31 reached 9.87 million. The stock has fallen by -0.86% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MRSN stock heading into the next quarter.
